Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 26, 2017 - Issue 3
Submit an article Journal homepage
382
Views
2
CrossRef citations to date
0
Altmetric
Review

Investigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease

Mario MalerbaDepartment of Internal Medicine, University of Brescia and ASST Spedali Civili, Brescia, ItalyCorrespondence[email protected]
View further author information
,
Alessandro RadaeliDepartment of Emergency, ASST Spedali Civili, Brescia, ItalyView further author information
,
Paolo MontuschiDepartment of Pharmacology, Faculty of Medicine, University Hospital Agostino Gemelli Foundation Catholic University of the Sacred Heart, Pharmacology, Rome, ItalyView further author information
,
Kesavan S. BabuDepartment of Respiratory Medicine, Queen Alexandra Hospital, Cosham, Portsmouth, UKView further author information
&
Jaymin B MorjariaDepartment of Respiratory Medicine, Royal Brompton & Harefield NHS Trust, Harefield Hospital, Harefield, UKView further author information
Pages 319-329 | Received 29 Sep 2016, Accepted 23 Jan 2017, Published online: 06 Feb 2017

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Robert M Burkes & Ralph J Panos. (2020) Ultra Long-Acting β-Agonists in Chronic Obstructive Pulmonary Disease. Journal of Experimental Pharmacology 12, pages 589-602.
Read now

Articles from other publishers (1)

Wijdan H. Ramadan, Sarah Al Masri & John Rizk. (2019) Fixed‐dose combination of umeclidinium and vilanterol for patients with chronic obstructive pulmonary disease: A systematic review. The Clinical Respiratory Journal 13:11, pages 663-673.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.